10-Q Filing

Cryoport, Inc. CIK: 1124524 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001144204-13-062580`
Period End Date	20130930
Filing Date	20131118
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	cyrx-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 64 Cash Flow Statement 74

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts receivable	`AllowanceForDoubtfulAccountsReceivable`	$16.80K	USD	Point-in-time
Allowance for doubtful accounts receivable	`AllowanceForDoubtfulAccountsReceivable`	$8.70K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$563.10K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$532.47K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.62M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Accounts receivable, net of allowances of $16,800 at September 30, 2013 and $8,700 at March 31, 2013	`AccountsReceivableNetCurrent`	$387.67K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowances of $16,800 at September 30, 2013 and $8,700 at March 31, 2013	`AccountsReceivableNetCurrent`	$217.10K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$43.30K	USD	Point-in-time
Inventories	`InventoryNet`	$39.21K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$138.89K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$40.69K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$958.30K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$516.63K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$505.49K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	58.15M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.76M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	58.15M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$272.26K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.76M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$216.82K	USD	Point-in-time
Deposits and other assets	`Depositsandotherassets`	$19.74K	USD	Point-in-time
Deposits and other assets	`Depositsandotherassets`	$19.74K	USD	Point-in-time
Total assets	`Assets`	$1.76M	USD	Point-in-time
Total assets	`Assets`	$1.76M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$602.96K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$858.71K	USD	Point-in-time
Accrued compensation and related expenses	`EmployeeRelatedLiabilitiesCurrent`	$342.43K	USD	Point-in-time
Accrued compensation and related expenses	`EmployeeRelatedLiabilitiesCurrent`	$217.43K	USD	Point-in-time
Convertible debentures payable and accrued interest	`ConvertibleDebtCurrent`	-	USD	Point-in-time
Convertible debentures payable and accrued interest	`ConvertibleDebtCurrent`	$1.30M	USD	Point-in-time
Current portion of related party notes payable	`NotesPayableRelatedPartiesClassifiedCurrent`	$96.00K	USD	Point-in-time
Current portion of related party notes payable	`NotesPayableRelatedPartiesClassifiedCurrent`	$96.00K	USD	Point-in-time
Derivative liabilities	`DerivativeInstrumentsAndHedgesLiabilities`	$1.20K	USD	Point-in-time
Derivative liabilities	`DerivativeInstrumentsAndHedgesLiabilities`	$20.85K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.04M	USD	Point-in-time
Related party notes payable and accrued interest, net of current portion	`NotesPayableRelatedPartiesNoncurrent`	$1.29M	USD	Point-in-time
Related party notes payable and accrued interest, net of current portion	`NotesPayableRelatedPartiesNoncurrent`	$1.32M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.34M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.82M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 2,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 2,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 58,146,502 shares issued and outstanding at September 30, 2013 and 37,760,628 shares issued and outstanding at March 31, 2013issued and outstanding at September 30, 2013 and 37,760,628 shares issued and outstanding at March 31, 2013	`CommonStockValue`	$37.76K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 58,146,502 shares issued and outstanding at September 30, 2013 and 37,760,628 shares issued and outstanding at March 31, 2013issued and outstanding at September 30, 2013 and 37,760,628 shares issued and outstanding at March 31, 2013	`CommonStockValue`	$58.15K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$64.21M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$81.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-82.59M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-66.31M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-577.88K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-2.06M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$1.76M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$1.76M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`SalesRevenueNet`	$579.83K	USD	1 Quarter
Net revenues	`SalesRevenueNet`	$233.60K	USD	1 Quarter
Net revenues	`SalesRevenueNet`	$424.90K	USD	2 Qtrs
Net revenues	`SalesRevenueNet`	$1.07M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$941.05K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$507.73K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$344.44K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$698.06K	USD	2 Qtrs
Gross margin (loss)	`GrossProfit`	$126.74K	USD	2 Qtrs
Gross margin (loss)	`GrossProfit`	$-273.16K	USD	2 Qtrs
Gross margin (loss)	`GrossProfit`	$72.10K	USD	1 Quarter
Gross margin (loss)	`GrossProfit`	$-110.84K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.34M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.24M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.61M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.46M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$211.08K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$210.61K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$118.44K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$101.66K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.44M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.67M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.36M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.82M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.55M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.09M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.55M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.29M	USD	1 Quarter
Debt conversion expense	`InducedConversionOfConvertibleDebtExpense`	$13.16M	USD	2 Qtrs
Debt conversion expense	`InducedConversionOfConvertibleDebtExpense`	-	USD	2 Qtrs
Debt conversion expense	`InducedConversionOfConvertibleDebtExpense`	-	USD	1 Quarter
Debt conversion expense	`InducedConversionOfConvertibleDebtExpense`	$13.16M	USD	1 Quarter
Interest expense	`InterestExpense`	$595.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$512.78K	USD	1 Quarter
Interest expense	`InterestExpense`	$36.36K	USD	2 Qtrs
Interest expense	`InterestExpense`	$11.76K	USD	1 Quarter
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$14.49K	USD	1 Quarter
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$33.82K	USD	2 Qtrs
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$892.00	USD	1 Quarter
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$19.65K	USD	2 Qtrs
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-13.67M	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-2.54K	USD	2 Qtrs
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$2.73K	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-13.74M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-14.96M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.55M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.10M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-16.28M	USD	2 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	$1.60K	USD	2 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$1.60K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.28M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.96M	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.42	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.38	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.76M	shares	1 Quarter
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	38.59M	shares	2 Qtrs
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	39.11M	shares	1 Quarter
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.76M	shares	2 Qtrs

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-16.28M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.96M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$216.93K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$178.99K	USD	2 Qtrs
Amortization of debt discount and deferred financing costs	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Amortization of debt discount and deferred financing costs	`AmortizationOfDebtDiscountPremium`	$515.38K	USD	2 Qtrs
Amortization of debt discount and deferred financing costs	`AmortizationOfDebtDiscountPremium`	$8.84K	USD	2 Qtrs
Fair value of stock options and warrants issued to employees, directors and consultants	`FairValueOfStockOptionsAndWarrantsIssuedToConsultantsEmployeesAndDirectors`	$-331.22K	USD	2 Qtrs
Fair value of stock options and warrants issued to employees, directors and consultants	`FairValueOfStockOptionsAndWarrantsIssuedToConsultantsEmployeesAndDirectors`	$-249.03K	USD	2 Qtrs
Change in fair value of derivative instruments	`UnrealizedGainLossOnDerivativesAndCommodityContracts`	$19.65K	USD	2 Qtrs
Change in fair value of derivative instruments	`UnrealizedGainLossOnDerivativesAndCommodityContracts`	$33.82K	USD	2 Qtrs
Loss on disposal of Cryogenic shippers	`DisposalGroupNotDiscontinuedOperationGainLossOnDisposal`	$-2.81K	USD	2 Qtrs
Loss on disposal of Cryogenic shippers	`DisposalGroupNotDiscontinuedOperationGainLossOnDisposal`	$-6.38K	USD	2 Qtrs
Debt conversion expense	`InducedConversionOfConvertibleDebtExpense`	$13.16M	USD	2 Qtrs
Debt conversion expense	`InducedConversionOfConvertibleDebtExpense`	-	USD	2 Qtrs
Debt conversion expense	`InducedConversionOfConvertibleDebtExpense`	-	USD	1 Quarter
Debt conversion expense	`InducedConversionOfConvertibleDebtExpense`	$13.16M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$170.57K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$24.24K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$4.17K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$4.09K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-27.34K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$9.63K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$78.30K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-221.52K	USD	2 Qtrs
Accrued compensation and related expenses	`IncreaseDecreaseInAccruedCompensationAndRelatedExpense`	$-125.00K	USD	2 Qtrs
Accrued compensation and related expenses	`IncreaseDecreaseInAccruedCompensationAndRelatedExpense`	$91.21K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$9.26K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$76.40K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.32M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.66M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$46.78K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$137.50K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-137.50K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-46.78K	USD	2 Qtrs
Proceeds from issuance of convertible debt	`ProceedsFromConvertibleDebt`	$2.62M	USD	2 Qtrs
Proceeds from issuance of convertible debt	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Repayments of convertible debt	`RepaymentsOfConvertibleDebenturesPayable`	-	USD	2 Qtrs
Repayments of convertible debt	`RepaymentsOfConvertibleDebenturesPayable`	$82.80K	USD	2 Qtrs
Payments of offering and deferred financing costs	`PaymentsOfFinancingCosts`	$242.61K	USD	2 Qtrs
Payments of offering and deferred financing costs	`PaymentsOfFinancingCosts`	$324.88K	USD	Point-in-time
Payments of offering and deferred financing costs	`PaymentsOfFinancingCosts`	$122.45K	USD	2 Qtrs
Repayments of related party notes payable	`RepaymentsOfRelatedPartyNotesPayable`	$40.00K	USD	2 Qtrs
Repayments of related party notes payable	`RepaymentsOfRelatedPartyNotesPayable`	$48.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromIssuanceOfWarrants`	$100.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromIssuanceOfWarrants`	-	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-245.25K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.42M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-30.64K	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.95M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$563.10K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$532.47K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.62M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$563.10K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$532.47K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.62M	USD	Point-in-time
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	$15.68K	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	$1.60K	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Release of restricted cash for repayment of convertible debentures payable	`ReleaseOfRestrictedCashForRepaymentOfConvertibleDebenturesPayable`	$251.37K	USD	2 Qtrs
Release of restricted cash for repayment of convertible debentures payable	`ReleaseOfRestrictedCashForRepaymentOfConvertibleDebenturesPayable`	-	USD	2 Qtrs
Offering Costs In Connection With Equity Financing Included In Accounts Payable	`OfferingCostsInConnectionWithEquityFinancingIncludedInAccountsPayable`	-	USD	2 Qtrs
Offering Costs In Connection With Equity Financing Included In Accounts Payable	`OfferingCostsInConnectionWithEquityFinancingIncludedInAccountsPayable`	$59.57K	USD	2 Qtrs
Deferred financing costs in connection with convertible debt payable included in accounts payable	`DeferredFinancingCostsInConnectionWithConvertibleDebtPayableIncludedInAccountsPayable`	-	USD	2 Qtrs
Deferred financing costs in connection with convertible debt payable included in accounts payable	`DeferredFinancingCostsInConnectionWithConvertibleDebtPayableIncludedInAccountsPayable`	$27.74K	USD	2 Qtrs
Estimated relative fair value of warrants issued in connection with convertible debt payable	`DebtConversionConvertedInstrumentAmountWarrantIssued`	-	USD	2 Qtrs
Estimated relative fair value of warrants issued in connection with convertible debt payable	`DebtConversionConvertedInstrumentAmountWarrantIssued`	$199.17K	USD	2 Qtrs
Conversion of Bridge Notes payable and accrued interest into shares of common stock and warrants	`DebtConversionConvertedInstrumentAmount1`	-	USD	2 Qtrs
Conversion of Bridge Notes payable and accrued interest into shares of common stock and warrants	`DebtConversionConvertedInstrumentAmount1`	$3.98M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.